Biotech | May 09, 2022
ExoCoBio receives Japanese patent for alleviating dermatitis
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad
Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
The company enters into collaborations with leading next-generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial
Subscribe To Our Newsletter & Stay Updated
